Search | Page 9 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. 5-Azacytidine in myelodysplastic syndromes: a clinical practice guideline.

    ... R, Yee K, Wells RA; Canadian Consortium on Evidence-based Care in MDS. Original Publication Date:  ... burden of morbidity and premature death. Although supportive or palliative measures such as blood transfusion have long ...

    Research Article last updated 10/11/2011 - 5:58pm.

  2. The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care in Subjects With Red Blood Cell (RBC) Transfusion-Dependent Anemia and Thrombocytopenia Due to International Prognostic Scoring System (IPSS) Low

    ... and Safety of Oral Azacitidine plus Best Supportive care versus Placebo and Best Supportive care in subjects with ...

    Clinical Trial last updated 04/27/2016 - 9:52am.

  3. Allo vs Hypomethylating/Best Supportive Care in MDS (BMT CTN 1102)

    ... (RIC-alloHCT), Arm 2: Non-Transplant Therapy/Best Supportive Care . Status:  Recruiting ...

    Clinical Trial last updated 04/28/2016 - 10:50am.

  4. MDS - Treatment (OLD)

    ... are not too low and your symptoms are not too bad Supportive care  to help you manage the symptoms of your MDS Drug Therapy with ...

    Topic section last updated 03/10/2016 - 11:01pm.

  5. Build a Health Care Team

    ... that you begin to see yourself as the center of your health care team. Only you can make sure you get your questions answered. Only you can ... Help arrange consultations with specialty doctors and  supportive care  providers Maintain your medical records in your ...

    Page last updated 06/30/2016 - 10:00am.

  6. Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia in Complete Remission (QUAZAR AML-001)

    ...

    Clinical Trial last updated 04/29/2016 - 8:39am.

  7. Chronic Myelomonocytic Leukemia (CMML)

    ... age and health. Treatment options include: Supportive care with blood transfusions, growth factors and antibiotics to treat ...

    Topic section last updated 12/16/2016 - 9:42am.

  8. A Phase III, International, Randomized, Controlled Study of Rigosertib versus Physician’s Choice of Treatment in Patients with Myelodysplastic Syndrome after Failure of a Hypomethylating Agent

    ... treatment, which may include any approved or standard-of-care therapy, based on frequently used treatment for MDS after receipt of HMAs ... treatment of MDS (other than growth factors and other supportive care measures) within 4 weeks of planned randomization ...

    Clinical Trial last updated 11/29/2016 - 8:29am.

  9. Selinexor (KPT-330) in Older Patients With Relapsed/Refractory AML (SOPRA)

    ... provided orally twice weekly in a dose of 60mg plus best supportive care (BSC) versus one of three physician choices. Patients must have ...

    Clinical Trial last updated 08/26/2016 - 9:21am.

  10. MDS Drug Therapy

    ... those taking azacitidine to those getting conventional care, including supportive care and chemotherapy . They found that about 5 in 10 ...

    Topic section last updated 03/10/2016 - 11:26pm.